Coya Therapeutics, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Coya Therapeutics, Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for June 25, 2026, to elect directors and ratify auditors.
NASDAQ
Coya Therapeutics will hold its annual stockholder meeting virtually on June 26, 2025, to vote on the election of directors and the ratification of its accounting firm.
NASDAQ
Coya Therapeutics will hold its annual stockholders meeting virtually on June 26, 2025, to elect directors and ratify the appointment of its independent accounting firm.
NASDAQ
Coya Therapeutics is holding its annual meeting to elect directors, approve an amendment to its equity incentive plan, and ratify its accounting firm.
NASDAQ
DEFA14A: Coya Therapeutics Sets Date for Annual Stockholder Meeting, Proposes Equity Incentive Plan Amendment
Coya Therapeutics announces its annual stockholder meeting to be held virtually on May 8, 2024, featuring proposals including director elections and an amendment to the equity incentive plan.
NASDAQ
Coya Therapeutics is asking stockholders to approve an amendment to its 2021 Equity Incentive Plan to increase the number of shares available for issuance by 750,000, aiming to attract and retain key talent.